These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 23773030)

  • 41. Sensitivity and specificity of Addenbrooke's Cognitive Examination, Mattis Dementia Rating Scale, Frontal Assessment Battery and Mini Mental State Examination for diagnosing dementia in Parkinson's disease.
    Kaszás B; Kovács N; Balás I; Kállai J; Aschermann Z; Kerekes Z; Komoly S; Nagy F; Janszky J; Lucza T; Karádi K
    Parkinsonism Relat Disord; 2012 Jun; 18(5):553-6. PubMed ID: 22405839
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The association of cognitive reserve with motor and cognitive functions for different stages of Parkinson's disease.
    Guzzetti S; Mancini F; Caporali A; Manfredi L; Daini R
    Exp Gerontol; 2019 Jan; 115():79-87. PubMed ID: 30502539
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Validity and metric of MiniMental Parkinson and MiniMental State Examination in Parkinson's disease.
    Isella V; Mapelli C; Morielli N; De Gaspari D; Siri C; Pezzoli G; Antonini A; Poletti M; Bonuccelli U; Picchi L; Napolitano A; Vista M; Greco A; Appollonio IM
    Neurol Sci; 2013 Oct; 34(10):1751-8. PubMed ID: 23423464
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Performance of Greek demented and nondemented subjects on the Greek version of the Mattis Dementia Rating Scale. A validation study.
    Katsarou Z; Bostantjopoulou S; Zikouli A; Kazazi E; Kafantari A; Tsipropoulou V; Kourtesi G; Peitsidou E
    Int J Neurosci; 2010 Nov; 120(11):724-30. PubMed ID: 20942587
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metric properties of the mini-mental Parkinson and SCOPA-COG scales for rating cognitive deterioration in Parkinson's disease.
    Serrano-Dueñas M; Calero B; Serrano S; Serrano M; Coronel P
    Mov Disord; 2010 Nov; 25(15):2555-62. PubMed ID: 20824734
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The frontal assessment battery as a tool for evaluation of frontal lobe dysfunction in patients with Parkinson disease.
    Cohen OS; Vakil E; Tanne D; Molshatzki N; Nitsan Z; Hassin-Baer S
    J Geriatr Psychiatry Neurol; 2012 Jun; 25(2):71-7. PubMed ID: 22689698
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationship between cognitive dysfunction and behavioural symptoms in Nigerian patients with Parkinson's disease no dementia.
    Ojagbemi A
    J Parkinsons Dis; 2013 Jan; 3(3):293-300. PubMed ID: 23963316
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A new device-aided cognitive function test, User eXperience-Trail Making Test (UX-TMT), sensitively detects neuropsychological performance in patients with dementia and Parkinson's disease.
    Kokubo N; Yokoi Y; Saitoh Y; Murata M; Maruo K; Takebayashi Y; Shinmei I; Yoshimoto S; Horikoshi M
    BMC Psychiatry; 2018 Jul; 18(1):220. PubMed ID: 29976167
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Psychiatric symptoms screening in the early stages of Parkinson's disease.
    Bugalho P; da Silva JA; Cargaleiro I; Serra M; Neto B
    J Neurol; 2012 Jan; 259(1):124-31. PubMed ID: 21691730
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cognitive status correlates with neuropathologic stage in Parkinson disease.
    Braak H; Rüb U; Jansen Steur EN; Del Tredici K; de Vos RA
    Neurology; 2005 Apr; 64(8):1404-10. PubMed ID: 15851731
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
    Aarsland D; Brønnick K; Larsen JP; Tysnes OB; Alves G;
    Neurology; 2009 Mar; 72(13):1121-6. PubMed ID: 19020293
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessing cognition in Parkinson disease: use of the cognitive linguistic quick test.
    Parashos SA; Johnson ML; Erickson-Davis C; Wielinski CL
    J Geriatr Psychiatry Neurol; 2009 Dec; 22(4):228-34. PubMed ID: 19666882
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rate of cognitive decline in premotor Parkinson's disease: a prospective study (NEDICES).
    Sánchez-Ferro Á; Benito-León J; Louis ED; Mitchell AJ; Molina-Arjona JA; Trincado R; Villarejo A; Bermejo-Pareja F
    Mov Disord; 2013 Feb; 28(2):161-8. PubMed ID: 23239285
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Psychometric attributes of the SCOPA-COG Brazilian version.
    Carod-Artal FJ; Martínez-Martin P; Kummer W; Ribeiro Lda S
    Mov Disord; 2008 Jan; 23(1):81-7. PubMed ID: 17987646
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A pilot study of psychometric properties of the Beijing version of Montreal Cognitive Assessment in patients with idiopathic Parkinson's disease in China.
    Nie K; Zhang Y; Wang L; Zhao J; Huang Z; Gan R; Li S; Wang L
    J Clin Neurosci; 2012 Nov; 19(11):1497-500. PubMed ID: 22959678
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Validation of a Spanish version of the Lille apathy rating scale for Parkinson's disease.
    García-Ramos R; Villanueva Iza C; Catalán MJ; Reig-Ferrer A; Matías-Guíu J
    ScientificWorldJournal; 2014; 2014():849834. PubMed ID: 25379547
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Domain-specific cognitive impairment in non-demented Parkinson's disease psychosis.
    Hinkle JT; Perepezko K; Bakker CC; Dawson TM; Johnson V; Mari Z; Marvel CL; Mills KA; Pantelyat A; Pletnikova O; Rosenthal LS; Shepard MD; Stevens DA; Troncoso JC; Wang J; Pontone GM
    Int J Geriatr Psychiatry; 2018 Jan; 33(1):e131-e139. PubMed ID: 28509347
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is the Random Forest Algorithm Suitable for Predicting Parkinson's Disease with Mild Cognitive Impairment out of Parkinson's Disease with Normal Cognition?
    Byeon H
    Int J Environ Res Public Health; 2020 Apr; 17(7):. PubMed ID: 32290134
    [TBL] [Abstract][Full Text] [Related]  

  • 60. French translation and normation of the Parkinson Neuropsychometric Dementia Assessment (PANDA).
    Gasser AI; Kalbe E; Calabrese P; Kessler J; Von Allmen G; Rossier P
    J Neurol Sci; 2011 Nov; 310(1-2):189-93. PubMed ID: 21764080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.